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 Chitosan microcapsules and tablets with Argentinean plants extracts were developed 
 Release of bioactive compounds from chitosan microcapsules was faster than from tablets  
 The encapsulation process did not affect the antioxidant or antifungal activity 
















The design of novel delivery systems to treat vaginal fungal infections is a topic of high interest. 
Chitosan, being itself antimicrobial and having good mucoadhesive properties, is an excellent 
candidate as a delivery matrix for active compounds. In this work, chitosan microcapsules 
containing dry extracts of Argentinean medicinal plants with proved biological properties (Larrea 
divaricata, L. cuneifolia, L. nitida, Zuccagnia punctata and Tetraglochin andina) were developed 
through electrospraying and compared with conventionally used tablets containing the same 
extracts. Total phenolics, loading efficacy, physical properties, morphology and particle size, 
molecular organization, water sorption capacity, release of bioactive compounds and biological 
properties were assessed. The encapsulation process or the inclusion in tablets did not degrade the 
bioactive compounds of the extracts. The release of phenolic compounds from chitosan 
microcapsules was faster than from tablets.  The fingerprint of released phenolic compounds from 
microcapsules and tablets was similar to that from the dry extracts and the antioxidant and 
antifungal capacity remained unchanged. The FT-IR analysis suggested interactions between the 
chitosan and the extracts, which explained why the microcapsules kept the integrity in slightly 
acidic media. Increased solubility of the extracts when incorporated in the microcapsules was seen 
in simulated vaginal fluid, potentially increasing the bioavailability of bioactive compounds in the 
vaginal environment.  
This work highlights the potential of the chitosan-based delivery systems for phytomedicines with 
antifungal and antioxidant activity to be used in vulvovaginal candidiasis.  
 
Abbreviation list: QE, quercetin equivalents; GAE, gallic acid equivalents; ABTS, 2,2'-azino-bis 
(3-ethylbenzothiazoline-6-sulfonic acid); BHT, butylated hydroxytoluene; RBC, red blood cells; 
AAPH, 2,2'-azobis(2-methyl-propionamidine) dihydrochloride; NDGA, nordihydroguaiaretic 
acid; TPC, Total phenolic compound; NF-P, Non-flavonoid phenols; FP, Flavonoid phenolic; 
DMAC, 4-dimethylaminocinnamaldehyde; PB2E, procyanidin B2 equivalents; GE, glucose 
equivalent; DW, dry weight; SEM, scanning electron microscopy; PBS, phosphate buffer saline; 
SVF, simulated vaginal fluid; 1,2dHGPC, 1,2-diheptanoylthio-glycerophosphocholine. 




In the last years, novel vaginal drug delivery formulations have focused attention to treat fungal 
infections. Candida species are the fourth leading agent of health care associated infections 
worldwide with the highest mortality rate of all nosocomial bloodstream infections, even 
exceeding those caused by Staphylococcus aureus and Pseudomonas aeruginosa (Bandara, 













The limited effectiveness of typical vaginal formulations like creams, suppositories or tablets are 
related to their low active residence time, small absorption area, barrier properties of mucosa and 
inadequate spreading of the formulation on vaginal surfaces (Marciello, Rossi, Caramella, & 
Remuñán-López, 2017). To improve effectiveness, new delivery systems based on nano- or 
microparticles have been developed (Ensign, Cone, & Hanes, 2014; Wong, Dhanawat, & 
Rathbone, 2014; Li et al., 2015, 2017; Gómez-Mascaraque et al., 2016). These smaller carriers 
have several advantages, including high specific surface area related to their small size, improved 
stability of the therapeutic agents incorporated, enhanced bioavailability and controlled release 
properties, making them attractive for practical pharmaceutical applications.  
Chitosan nano- and microparticles have high potential for vaginal drug delivery applications, 
because of the excellent properties of this carbohydrate polymer including good biocompatibility, 
low toxicity, mucoadhesivity and inherent antimicrobial properties, which have boosted a number 
of developments in this area (Andersen et al., 2017; Marciello et al., 2017). Chitosan has been 
reported to inhibit the adhesion of C. albicans to human vaginal epithelial cells (Knapczyk, 
Macura, & Pawlik, 1992; Li et al., 2009). Amongst the techniques that can be used to generate 
chitosan nano- and microparticles, electrospraying has gained increased attention. This technique 
can produce microencapsulation structures in a one-step process, under mild conditions, in the 
absence of organic/toxic solvents, limiting inactivation of the bioactive compounds and being 
adequate for both hydrophilic and hydrophobic drugs or ingredients with generally high loading 
efficiencies (Gómez-Mascaraque, Sánchez, & López-Rubio, 2016).  
The side effects of antifungal agents currently used in commercial formulations (Sawant & Khan, 
2017) and the very high recurrence rates observed (Bradshaw & Sobel, 2016), encourage 
alternative therapeutic approaches, which include the use of natural antifungal extracts.  
Plants occurring in the semiarid and arid regions of Argentina have been widely used in traditional 
medicine to treat fungal and bacterial infections and as anti-inflammatory (Barboza, Cantero, 
Nuñez, Pacciaroni, & Ariza Espinar, 2009; Butassi et al., 2015; Quiroga, Sampietro, & Vattuone, 
2001; Stege et al., 2006; Svetaz et al., 2010; Torres, Urbina, Morales, Modak, & Delle Monache, 
2003; Vogt, Cifuente, Tonn, Sabini, & Rosas, 2013; Zampini, Cudmani, & Isla, 2007). 
The hydroalcoholic extracts of the shrubs Larrea divaricata, L. cuneifolia, L. nitida  
(Zygophyllaceae), Zuccagnia punctata (Fabaceae) and Tetraglochin andina (Rosaceae) contain a 
distinctive array of phenolic compounds, which are species-dependent and show good to excellent 
antioxidant capacity and antifungal activity against Candida albicans and non-albicans isolated 
from vaginal infections (Agüero et al., 2011; Blecha et al., 2007; Carabajal, Isla, & Zampini, 













activity make these extracts excellent candidates to be used in vaginal formulations against 
candidiasis. The aim of the present work was to develop electrosprayed chitosan-based delivery 
systems for vaginal administration of selected medicinal plant extracts.  The efficacy and release 
properties of the chitosan-based preparations from the above mentioned Argentinian species were 
compared with tablets containing the same extracts. The morphology, drug loading, water sorption 
ability and functional properties (antifungal and antioxidant activities) of these novel delivery 
systems were also characterized.  
 
2. Materials and Methods 
2.1. Reagents 
Chitosan (reported degree of deacetylation 85 ± 2.5 % and an average molecular weight of 25 
kDa) was purchased from Heppe Medical Chitosan GmbH. 2,2’-azino-bis(3-ethylbenzothiazoline-
6-sulfonic acid) diammonium salt (ABTS) and 2,2′-azobis(2-methylpropionamidine) 
dihydrochloride (AAPH) were obtained from Sigma-Aldrich. Carbopol 934, hydroxypropylmethyl 
cellulose (molecular weight 26,000, viscosity 80-120 cP) and sodium carboxymethylcellulose 
(NaCMC, molecular weight 250,000, substitution degree 0.7) were purchased from Sigma-
Aldrich. All solvents used were of analytical grade. 
 
2.2. Plant material 
   The plant parts used were leaves and stems (aerial parts), according to the traditional use. 
Zuccagnia punctata Cav. (Zp), Larrea cuneifolia Cav. (Lc) and L. divaricata Cav. (Ld) were 
collected in April 2015 at Amaicha del Valle, Tucumán, Argentina at 2000 m.a.s.l., Larrea nitida 
(Ln) was collected in April 2015 at Vinchina, La Rioja, Argentina at 3485 m.a.s.l. Tetraglochin 
andina Ciald (Ta) was collected from January to February 2015 in Huaca Huasi, Tucumán, 
Argentina (4300 m.a.s.l.). The plants are shown in Figure 1. Voucher specimens (L. cuneifolia: 
LIL 614829; L. divaricata: LIL 614299; L. nitida: LIL 615845; Z. punctata LIL 605935; T. 
andina LIL 610669) were deposited at the Herbarium of Fundación Miguel Lillo (Tucumán, 
Argentina). The samples were dried in a forced air oven at 40°C.  












   




Figure 1. The plant species investigated. A) Larrea cuneifolia Cav.; B) Larrea divaricata Cav.; 
C) Larrea nitida Cav.; D) Zuccagnia punctata Cav.; E) Tetraglochin andina Ciald. The pictures 
were obtained by the authors during samples collection in the places where these plant species 
grow. 
 
2.3. Dry extract preparation  
   The powdered air-dried plant material (10 g) was macerated in 200 mL of 60° ethanol for 1 h 
with ultrasonic application five times for 10 minutes. Combined extracts were filtered, taken to 
dryness under reduced pressure and then freeze-dried to afford the extracts. The w/w extraction 
yield was determined. Dry extracts were placed in oxygen barrier bags and vacuum-packed 
(Multivac, D-8941, Germany) and stored at room temperature. The dry extract was dissolved in 
ethanol 60° to carry out the phytochemical and biological assays. 
 













 Chitosan solutions 5% (w/v) were prepared by dissolving the polysaccharide in 80% acetic acid 
(v/v) at room temperature under magnetic stirring. Dry plant extracts (10% w/w of the total solids 
content) were added to the chitosan solutions and the mixtures were stirred until complete 
dissolution. The final solutions were electrosprayed following the procedure optimized in a 
previous work (Gómez-Mascaraque et al., 2016). Briefly, samples were electrosprayed by using a 
home-made electrospinning/electrospraying apparatus, equipped with a variable high-voltage 0-30 
kV power supply, at a steady flow-rate of 0.15 mL/h, an applied voltage of 17 kV and a syringe 
tip-collector distance of 10 cm. Processed samples were collected on a stainless-steel plate. The 
obtained dry powdered material was stored in a desiccator until use.  
 
2.5. Design of tablets for vaginal delivery 
Extract-free tablets (placebo) and dry extract-containing tablets were prepared. The composition 
of the tablets was as follows: carbopol 934P (100 mg), hydroxylpropylmethyl cellulose (100 mg), 
carboxymethyl cellulose (50 mg), sodium bicarbonate (15 mg), citric acid (5 mg), magnesium 
stearate (2.5 mg), dry extract (1.5-10 mg). The tablets were compressed on a single punch tablet 
machine (Fareast, Shanghai, China) with a pressure of 14.3 kN.  
    
2.6. Phytochemical analysis of dry extracts 
   Total phenolic (TP) content was determined by the Folin–Ciocalteau method (Costamagna, 
Ordoñez, Zampini, Sayago, & Isla, 2013). Non-flavonoid phenols (NF-P) were determined in the 
supernatant by the Folin–Ciocalteau method after precipitation of the flavonoids with acidic 
formaldehyde (Isla, Salas, Danert, Zampini, & Ordoñez, 2014). Flavonoid phenolic (FP) content 
was calculated by difference between TP and NF-P. Flavone and flavanone content was 
determined (Costamagna et al., 2013). The total condensed tannin (proanthocyanidins) and 
hydrolyzed tannins content was quantified according to Torres Carro, Isla, Ríos, Giner, & Alberto, 
2015. 
 
2.7. Identification of phenolic compounds 
   The Z. punctata extract was analyzed by HPLC-ESI-MS/MS to identify its constituents. Mass 
spectra were recorded using an Agilent 1100 (Agilent Technologies Inc., CA, USA) liquid 
chromatography system connected through a split to an Esquire 4000 Ion Trap LC/MS(n) system 
(Bruker Daltoniks, Germany). Ionization was performed at 3000 V assisted by nitrogen as 
nebulizing gas at 50 psi and as drying gas at 365ºC and a flow rate of 10 L/min. Negative ions 













with 0.6 FWHM/m/z). The trap parameters were set in ion charge control (ICC) using 
manufacturer default parameters, and maximum accumulation time of 200 ms. The mass 
spectrometric conditions for analysis were: electrospray needle, 4000 V; end plate offset, -500 V; 
skimmer 1, 56.0 V; skimmer 2, 6.0 V; capillary exit offset, 84.6 V; capillary exit, 140.6 V. 
Collision induced dissociation (CID) spectra were obtained with a fragmentation amplitude of 
1.00 V (MS/MS) using helium as the collision gas and was automatically controlled through 
SmartFrag option. The mixture was analyzed using a MultoHigh 100 RP 18-5µ (250 x 4.6 mm) 
column (CS-Chromatographie Service GmbH, Langerwehe, Germany) maintained at 25 °C. The 
HPLC-MS analyses were performed using a linear gradient solvent system consisting of 1% 
formic acid in water (A) and acetonitrile as follow: 15% to 25% B over 15 min, increasing to 30% 
B at 30 min, changing to 40% B at 37 min, 48% to 51% B from 40 to 70 min, 53% to 55% B from 
75 to 78 min,60% to 100% B from 81 to 85 min, maintained to 100% B from 90 to 95 min and 
returning to 15% B from 95 to 105 min. The flow rate was 0.5 mL/min and the volume injected 
was 20 µL. The compounds were monitored at 254 nm. 
 
2.8. Characterization of microcapsules and tablets 
2.8.1. Loading efficiency   
To release all phenolic compounds included in the microcapsules and tablets, both formulations 
were macerated in 60° ethanol for 1 h with ultrasonic application (10 minutes, five times). Then, 
each one was centrifuged at 2,950 ×g for 5 min. The supernatants were gathered. Aliquots of the 
supernatant were taken for total phenolic compounds determination according to Costamagna et 
al., 2013. The loading efficiency (%) was determined as LE=100 x RPC/ TPC, where LE: loading 
efficiency; RPC: released phenolic compounds; TPC: total phenolic compounds. 
 The phenolic compounds eluted were identified by HPLC-DAD and its chromatographic profile 
was compared with dry extract profiles. The HPLC system consisting of a Waters 1525 Binary 
HPLC Pumps system with a 1500 Series Column Heater, a manual injection valve with a 20 μL 
loop (Rheodyne Inc., Cotati, CA) and a Waters 2998 photodiode array detector (PDA) were used 
to analyze the extracts, microcapsules and tablets. An XbridgeTM 135 C18 column (4.6 x 150 
mm, 5 μm; Waters Corporation, Milford, MA). The solvent system for the separation of 
components was composed of solvent A (0.1% acetic acid) and solvent B (0.1% methanol) 
(conditions: 10–57% B from 0 to 45 min and kept at 100% B from 45 to 60 min). The low rate 
was set at 0.5 mL/min. A solution of 2 mg DW/mL was used. Data collection was carried out with 
EmpowerTM 2 software. The identification of phenolic compounds was carried out by comparing 













Sigma-Aldrich (MO, USA) and Fluka Chemical Corp. (USA). Experiments were performed in 
independent triplicates.  
 
2.8.2. Evaluation of Physical Properties of the tablets   
The weight, thickness, diameter, and hardness of 10 tablets of each formulation were measured. 
Hardness or tensile strength (TS) of the tablets was determined using a tablet hardness tester 




where F is the maximal diametrical crushing force, and d and t are the diameter and thickness of 
the tablet, respectively. The TS of each formulation was measured in triplicate. The disintegration 
test (DT) was performed according to the Real Spanish Pharmacopoeia, 1st edition, using a 
disintegration tester (Equipos Farmacéuticos®, Argentina) and purified water (as a solvent) at 37 
°C. DT was defined as the interval required for the complete disappearance of a tablet or its 
particles from the tester net. DT was measured for six tablets of each formulation. The friability of 
the tablets was determined by a friability tester (Equipos Farmacéuticos®, Argentina) based on the 
Real Spanish Pharmacopoeia, 1st edition. These tablets were then accurately weighed (M1), 
placed in the drum of the machine, and rotated at 25 rpm for 100 times. Finally, the rotated tablets 
were accurately weighted (M2). 
 
Friability (%) = (M1-M2/M1)X100 
 
2.8.3. Morphological characterization of microcapsules and tablets 
   Morphological characterization of microcapsules and tablets was conducted by scanning 
electron microscopy (SEM) on a Hitachi microscope (S-4800). The samples were sputter-coated 
with a gold‑palladium mixture prior to examination. Particle size distributions were obtained from 
the SEM micrographs from a minimum of 200 measurements per image in their original 
magnification using the FIJI software.  
 
2.8.4. Fourier-transform infrared (FT-IR) analysis 
   Samples (ca. 1-2 mg) of the plant extracts as well as microcapsules and tablets containing the 
extracts were grounded and dispersed in about 130 mg of spectroscopic grade KBr. A pellet was 













transmission mode using a Bruker (Rheinstetten, Germany) FT-IR Tensor 37 equipment. The 
spectra were obtained by averaging 10 scans at 1 cm-1 resolution. 
 
2.8.5. Swelling of microcapsules and vaginal tablets 
   The swelling ability of microcapsules and tablets was assessed by measuring their water uptake 
capacity following a method adapted from Bigucci et al., 2015. Samples (ca. 25 mg) were placed 
on circular pieces of filter paper (d = 50 mm), previously soaked with the swelling medium and 
placed on a cotton disc inside a Petri dish filled with 5 mL of the same medium. The swelling 
medium was made up of PBS adjusted with orthophosphoric acid to pH 4.5 to simulate vaginal 
conditions. At different time intervals, the filter paper plus the swollen microcapsules were 
weighed and then returned to the same Petri dish. Water uptake (WU) was calculated,  
 
  
where W0 is the initial mass of dry microcapsules and Wt is the mass of swollen microcapsules at 
time t. Experiments were performed in independent triplicates. 
 
2.8.6. In-vitro release of extracts from microcapsules and tablets 
   The in-vitro release of the different plant extracts from chitosan microparticles was assessed 
following a method adapted from Gómez-Mascaraque, Lagarón, & López-Rubio, 2015. The 
microcapsules (5 mg/mL) were suspended in the same phosphate buffer used for the swelling 
assays (pH 4.5) and stored at 37ºC (i.e. physiological temperature). At different time intervals, 
dispersions were centrifuged at 2,950 ×g and 37 ºC for 5 min using an Eppendorf 5804 R 
centrifuge (Hamburg, Germany). Aliquots (0.25 mL) of the supernatant were taken for sample 
analysis. The aliquot volume was then replaced by fresh release buffer. The extracted aliquots 
were analyzed by UV-Vis spectroscopy using a NanoDrop 1000 spectrophotometer (Thermo 
Fisher Scientific, USA) by measuring their absorbance at 280 nm. Calibration curves were 







T.andina= 0.9999). As plant extracts are 
only partially soluble in aqueous buffer, calibration curves correlate the absorbance at 280 nm 
with the concentration of the soluble fraction extracted from each plant extract in the buffer. For 
comparison purposes, the release of the extracts was also evaluated from vaginal tablets. The 
tablets were introduced in the required volume of medium to achieve the same extract 













procedure previously described was followed. Experiments were performed in independent 
triplicates. 
 
2.8.7. Release of phenolic compounds from microcapsules and tablets in simulated vaginal fluid  
  A medium was developed to simulate the fluid produced in the human vagina (das Neves et al., 
2008). The simulated vaginal fluid (SVF) composition in g/L was as follows: NaCl, 3.51; KOH, 
1.40; Ca(OH)2, 0.222; bovine serum albumin, 0.018; lactic acid, 2.00; acetic acid, 1.00; glycerol, 
0.16; urea, 0.4; glucose, 5.0 (das Neves et al., 2008). The mixture was adjusted to pH 4.2. The 
microcapsules and tablets were maintained at 37°C during 24 h in 9 mL of SVF since daily 
vaginal secretions were estimated in a range of 1–11 mL. Released TPC content was determined 
by the Folin–Ciocalteau method (Costamagna et al., 2013) at different time intervals. The relative 
percentage was calculated considering the phenolic compounds content of dry extracts used for the 
formulation of microcapsules and tablets as 100%. The phenolic compounds released were 
identified by HPLC-DAD. Experiments were performed in independent triplicates. 
 
2.9. Biological activity determinations in extracts, microcapsules and tablets 
To assess whether the polyphenols released from the microcapsules and the tablets during 24 h 
were active, the microcapsules and tablets were contacted with PBS and then centrifuged. The 
supernatant was freeze-dried and resuspended in 60° ethanol. The phenolic compounds content 
was determined to carry out the tests at the same concentration in which the extracts have activity 
(Moreno et al., 2018a, b).  
 
2.9.1. Antimicrobial assays 
Candida strain 
   Candida strains were provided by Instituto Nacional de Enfermedades Infecciosas- 
Administración Nacional de Laboratorios e Institutos de Salud (INEI-ANLIS) ‘Dr. Carlos G. 
Malbrán’, Buenos Aires, Argentina. Candida albicans (144783; 134333; 2089), C. glabrata 
(031646; 042030; 031982), C. tropicalis (1841), S. cerevisiae (134528; 134544; 124263), C. 
parapsilosis DMic 134410 and C. krusei DMic 134409 were used. All the microorganisms were 
maintained in brain–heart infusion containing 30% (v/v) glycerol at -20°C.  
Inoculum preparation 
The suspensions of each strain were transferred to Yeast Medium (malt extract 0.3%, yeast extract 













colonies were isolated and suspended in 0.9% NaCl solution. The inocula were prepared by 
adjusting the suspension turbidity to match the 0.5 McFarland scale (1-5x106 cells/mL). The cell 
number was estimated using a serial dilution technique according to the recommendations of the 
M27-A3-S4 reference document of Clinical and Laboratory Standards Institute (CLSI, 2012) for 
each assay. 
 
MIC determination for yeast 
   MIC values of dry extracts, microcapsules and tablets against Candida and Saccharomyces were 
determined by the macrodilution method (CLSI, 2012) The dry extracts (6.25–400 µg/mL) and the 
phenolic compounds eluted from microcapsules and tablets contained in a final volume of 1 mL 
were added to 9 mL of Sabouraud agar and then were put in Petri dishes. The inoculum (2µL) 
containing 0.5-2.5×103 CFU were seeded, and plates were aerobically incubated at 37°C. After 
incubation for 48 h, fungal growth was evidenced in each plate. The MIC (lowest concentration of 
extract without macroscopically visible growth) was determined.  
 
Microbiological control 
   Tablets and microcapsules containing plant extracts were dissolved in sterile PBS at 37°C for 
2h. Each sample aliquot was taken and spread with Drigalsky spatula in Petri dishes containing 
Mueller Hinton Medium (Britania) and Mold and Yeast Medium (Britania). The plates were 
incubated at 37°C and 28°C for 48 h, respectively. Sterility and solvent controls and controls of 
microcapsules and tablets without extracts were made. Microbial growth was analyzed after 
incubation. 
 
2.9.2. Antioxidant activity 
Total antioxidant capacity assay  
   The antioxidant capacity of the dry extracts, microcapsules and tablets (concentration range 
between 0.1 and 11 µg GAE/mL) was carried out by the improved ABTS radical cation (ABTS●+) 
method as described by Costamagna et al., 2013. Results were expressed as the concentration of 
extract required to scavenge 50% of ABTS●+ (SC50). The negative control was performed with the 
vehicle (ethanol 60°). Butylated hydroxytoluene (BHT), quercetin and nordihydroguaiaretic acid 
(NDGA) were used as reference compounds. 
Protection against oxidative hemolysis  
   The protection of oxidative hemolysis of red blood cells (RBC) by the dry extracts, 












according to Mendes, De Freitas, Baptista, & Carvalho, 2011, using azo compound solution [2,2′-
Azobis(2-methylpropionamidine) dihydrochloride] (AAPH). The extent of hemolysis was 
quantified spectrophotometrically at 545 nm. Percentage of hemolysis was calculated and the IC50 
values were determined as the concentration needed to protect the RBC from oxidative hemolysis 
by 50%. For the 100% hemolysis control, ethanol 60° was used as solvent control instead of the 
extracts. BHT, quercetin and NDGA were used as reference compounds. 
 
Statistical analyses 
Analyses were conducted at least three times with three different samples. Each experimental 
value is expressed as the mean ± standard deviation (SD). The statistic software InfoStat (Student 
Version, 2011) was used to evaluate the significance of differences between groups. The one-way 
ANOVA with Tukey post-test at a confidence level of 95% was used for the comparisons between 
groups. The criterion of statistical significance was taken as p ≤ 0.05.  
 
3. Results and Discussion 
3.1. Phytochemical analysis of dry extracts  
   Studies were performed with the dry hydroalcoholic extracts from the aerial parts of the five 
selected Argentine medicinal plants used in traditional medicine. Extracts contained a high level 
of total phenolic (TP between 354.7 to 397.9 mg GAE/g dry extract) and flavonoid phenolic 
compounds (FP between 201.6 to 260.4 mg GAE/g dry extract). The condensed tannin content 
ranged between 25.06 and 135.2 mg/g dry extract. Hydrolyzed tannin was detected in Z. punctata 
and T. andina. The results are summarized in Table 1. 
In previous studies, it was determined the phytochemical composition of Larrea species and T. 
andina by HPLC-ESI-MS/MS (Moreno et al., 2018a, b). The Tetraglochin extract was particularly 
rich in hydrolysable and condensed tannins, containing mainly mono-, di- and trigalloylhexosides, 
ellagitannins such as pedunculagin, gallo-ellagitannin, condensed tannins including (epi)catechin 
dimer and trimer as well as benzoic acids derived phenolics (Moreno et al., 2018a). The high 
tannin content agrees with the results obtained in the spectrophotometrical analysis (Table 1). 
Antioxidant, antimicrobial, anti-inflammatory, antitumor and hepatoprotective activities were 
previously demonstrated for ellagitannins (Moreno et al., 2018a). On the other hand, Larrea 
species were richer in nordihydroguayaretic acid (NDGA) and its derivatives, cyclolignans and 
epoxylignans, compounds with antiinflammatory, antitumoral, antifungal and antioxidant 
properties (Moreno et al., 2018b). The occurrence of chalcones in Zuccagnia punctata was 













punctata was analyzed. Some 23 compounds were identified, including seven condensed tannins, 
seven flavonoid glycosides, one flavonoid, five phenolic acid derivatives and three chalcones 
(Table 2).  
 
Table 1. Phytochemical composition of dry extracts from the selected Argentinean medicinal plants. 
Phytochemical content L. cuneifolia L. divaricata L. nitida Z.punctata T. andina 
Total free phenolics 
(mg GAE/g DW) 
397.9±2.7d 397.4±3.1d 370.6±1.5b 354.7±2.7a 386.9±1.7c 
Non-flavonoid 
phenolics (mg GAE/g 
DW) 
157.5±5.0b 162.6±6.7b 169.0±10.2b 128.9±12.6a 126.5±2.3a 
 
Flavonoid phenolics 
(mg GAE/g DW) 




Flavone and flavanone 
(mg QE/g DW) 















(mg GAE/g DW) 





GAE: gallic acid equivalents, QE: quercetin equivalents, PB2E: procyanidin B2 equivalents; DW: dry weight; Values are reported 
as mean ± standard deviation of triplicates. Different letters in the same line indicated significant differences in the content of the 
phytochemical components according to Tukey's test (p ≤ 0.05). ND: not detected. 
Table 2. Identification of Zuccagnia punctata phenolics by HPLC-MS-MS in the negative ion 
mode 
Compound Rt (min) [M-H]- MS/MS Identification 
1 5.7 191 172 (80), 126 (100), 110 (44), 
92 (86), 84 (92) 
Quinic acid 
2 7.9 343 191 (100) Galloylquinic acid 
3 10.6 577 559 (24), 451 (73), 425 (100), 
407 (19), 289 (16) 
Catechin dimer 
4 11.2 495 343 (100), 191 (6) Digalloylquinic acid 
5 12.0 577 559 (19), 451 (70), 425 (100), 
407 (14), 289 (8) 
Catechin dimer 
6 12.3 865 739 (26), 713 (26), 695 (68), 
577 (100) 
Catechin trimer 
7 13.8 289 245 (100) Catechin 
8 15.5-15.8 729 577 (100) Catechin dimer gallate 
9  22.4 609 301 (100) Q-rutinoside 
10 23.7 761 609 (18), 459 (18), 301 (100) Q-rutinoside gallate 
11 23.9 463 301 (100) Q-hexoside 
12 24.5-25.7 615 301 (100) Q-hexoside gallate 
13 30.0-31.1 585 301 Q-derivative 
14 34.0-35.0 419 257 (31), 239 (66), 213 (100) Trihydroxydihydrochalcone hexoside 
15 44.0 579 271 (100) Naringenin rutinoside 
16 46.0-46.4 561 269 (100), 213   Galangin dirhamnoside 
17 47.9-48.5 343 179 (100) 1-Methyl-3-(3′,4′-dihydroxyphenyl)-
propyl caffeate 
18 52.6-53.2 327 179 (100), 135 (14) 1-Methyl-3-(4′-hydroxyphenyl)-propyl 
caffeate 
19 55.3 255 227 (23), 213 (29), 211 (31) Pinocembrin 














21 66.8 241 197 (42), 149 (48), 109 (33) 2′,4′-Dihydroxydihydrochalcone 
22 68.5-70.2 239 197(92), 153(10), 135(26) 2′,4′-Dihydroxychalcone  
23 73.0-73.9 311 179(100), 135(4) 1-Methyl-3-(phenyl)-propyl caffeate 
 
 
Figure 2. HPLC-MS chromatogram of Zuccagnia punctata extract. Detection: all MS, negative 
ion mode.   
 
3.2. Physical and morphological Characterization of Tablets.  
Bioadhesive tablet formulations of ketoconazole for vaginal delivery based on Carbopol 934P, in 
combination with HPMC at different ratios, sodium bicarbonate and citric acid were formulated 
and assayed previously by other authors (Wang & Tang, 2008). The design of bioadhesive tablets 
for vaginal delivery using Carbopol 934P, in combination with HPMC and an effervescent 
mixture of sodium bicarbonate and citric acid to promote disintegration and delivery of medicinal 
plants from Argentina was described for the first time in this paper. The tablets formulated had an 
average weight of 272.5±10 mg, 12±0.1 mm diameter and 2.0±0.1 mm thickness. They showed a 
loading efficiency between 80 to 90% in all cases. However, extract accumulations could be 
visually observed in the surface of vaginal tablets, suggesting that the miscibility of the extracts 
with the tablet ingredients was low. All tablets showed adequate disintegration properties (DT 
between 204 min). The TS values were around of 1.34 ± 0.13 MPa. The friability percentages 
were low, between 0-0.71%. These values are acceptable according to the European 
Pharmacopoeia, United States Pharmacopoeia and Argentine Pharmacopeia. According to our 
results all loaded inserts, could be handled without damage during vaginal application. The 
presence of extracts in the tablets produced a rough and less porous surface rather than smooth as 
unloaded tablets. SEM images showed that the particles in all tablets containing plant extracts 
















Figure 3: SEM images tablet containing Larrea extracts (Mag 250 X) and its magnified field (Mag 10.00 KV).  
 
3.3. Morphological characterization of the microcapsules and loading efficiency 
   The electrospraying technique has previously yielded smaller particles than other common 
encapsulation techniques such as spray-drying despite requiring higher polymer concentrations for 
processing (Gómez-Mascaraque & López-Rubio, 2016). The morphology of the chitosan-
encapsulated extracts obtained by electrospraying is shown in Figure 4. The microcapsules 
structures containing different extracts exhibited by SEM a similar morphology to that previously 
observed for unloaded and (–)-epigallocatechin gallate-loaded chitosan particles prepared using 
the same electrospraying conditions (Gómez-Mascaraque et al., 2016). In this work, extracts 
containing complex polyphenols mixtures were encapsulated, which probably produced less 
homogeneous microcapsules, as deduced from the particle size distribution graphs which showed 
a much greater variation in capsule diameter than that observed when the pure polyphenolic 
compound was encapsulated. Depending on the extract incorporated, variations in size and 
morphology of the capsules were observed. Smaller particles were obtained for L. cuneifolia 
extract. As the encapsulation matrix and processing parameters were the same in all cases, the 
differences could be attributed to changes in the chitosan solution properties upon addition of the 
extracts (Chakraborty, Liao, Adler, & Leong, 2009). In all cases a loading efficiency was between 
75 and 90%. The chromatography profile of each of them was similar to dry extracts of each plant 
































Figure 4. SEM images and particle size distribution graphs of chitosan nano- and microparticles 
containing extracts from Zuccagnia punctata (a), Tetraglochin andina (b), Larrea cuneifolia (c), 
L. divaricata (d) and L. nitida (e). Scale bars correspond to 2 µm.    
 
3.4. Fourier transform-infrared (FT-IR) analysis of microcapsules and tablets 
   The FT-IR spectra of the L. divaricata extract in its free form and encapsulated within 
electrosprayed chitosan microstructures, together with the unloaded chitosan microcapsules is 
shown in Figure 5A.  The FT-IR spectra of all other extracts are shown as Supplementary 
Material. The FT-IR spectrum of electrosprayed chitosan showed a broad band with a maximum at 
3400 cm-1, attributed to the –OH and –NH stretching vibrations. Other characteristic bands of this 
polysaccharide were observed at 2929 cm-1 (C–H bonds stretching), 1633 cm-1 (amide I, C=O 
stretching), 1560 cm-1 (–NH2 bending), 1410 cm
-1 (–CH3 bending) and 1078 cm
-1 (C–O stretching 
of sugar rings) (Azevedo, Santhana Mariappan, & Kumar, 2012; Gómez-Mascaraque, Méndez, 
Fernández-Gutiérrez, Vázquez, & San Román, 2014). The spectra of the plant extracts were 
characterized by the presence of absorption bands at 3395 cm-1, 2960-2930 cm-1, 1730-1700 cm-1 
and in the 1600–800 cm-1 region attributed to the stretching, bending and deformation vibrations 
of polyphenolic compounds (Sivam, Sun-Waterhouse, Perera, & Waterhouse, 2012). 
   The incorporation of plant extracts within the chitosan particles caused some changes in the 
relative absorbance of the characteristic bands of chitosan, due to the contribution of the extracts 
to the infrared spectra. In all cases, a decrease in the relative intensity of the bands attributed to the 
–OH and –NH stretching band at 3400 cm-1 and the amide I and –NH2 bending bands at 1633 and 
1560 cm-1, respectively, was observed. This could also point out to interactions between the 
chitosan matrix and the polyphenolic extracts, which would be mainly mediated by hydrogen 
bonding or hydrophobic interactions, as generally accepted for polysaccharides-polyphenols 
interactions (Gómez-Mascaraque et al., 2017; LeBourvellec et al., 2012; 2004). A shift towards 
lower wavenumbers of the C-O stretching band in the sugar rings suggested a change in the 
polymer conformation upon incorporation of the extracts, suggesting intermolecular interactions 
between the polysaccharide and the extracts. Figure 5B shows the FT-IR spectra of the placebo 
tablets and the tablets containing L. divaricata extract as a representative example. The spectra of 
the tablets containing the other extracts are included as Supplementary Material. Given the 
complex composition of the extracts, it is difficult to unambiguously describe the spectral bands of 
































































Figure 5. A) FT-IR spectra of L. divaricata extract, together with unloaded and extract-loaded 
chitosan capsules, B) detail of the previous spectra in the region from 2000 to 800 cm-1 and C) FT-
IR spectra of unloaded and extract-loaded tablet with L. divaricata. 
 
3.5. Swelling of microcapsules and tablets 
   The water uptake (WU) capacity of encapsulated plant extracts in simulated vaginal fluid was 
calculated according to Eq. (1). The obtained profiles are shown in Figure 6A. All chitosan-based 
encapsulation structures presented a fast swelling upon contact with the aqueous buffer due to the 
hydrophilic nature of the polysaccharide, reaching WU values as high as 80-90% (i.e. water 
accounted for up to 80-90% of the total weight of the hydrated microcapsules). Small differences 
were observed among the samples, suggesting that the extent to which the incorporation of 
extracts affected the polymer conformation (see previous section) and the extent of interactions 
between matrix and polyphenol-rich extracts varied among the different extracts, having an impact 
on the swelling capacity of the chitosan matrix.  
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Figure 6. Swelling profiles in PBS buffer (pH = 4.5) of the extract-loaded and unloaded: A) 














 The unloaded chitosan microcapsules were also evaluated for comparison purposes. While the 
WU capacity of the extract-loaded samples remained almost constant after the initial rapid 
swelling, the values of the WU start to decrease after 1h for unloaded chitosan, as the weight of 
the hydrated microcapsules was found to decrease (Fig. 6A). A similar weight loss had been 
previously observed for chitosan-based hydrogels during swelling experiments and was attributed 
to the dissolution of a fraction of chitosan molecules in the buffer (Azevedo et al., 2012). Hence, 
the presence of the different plant extracts within the chitosan matrix was found to stabilize the 
microhydrogels formed thereof, delaying the dissolution of the polysaccharide (a lower weight 
loss was observed in the extract-containing microcapsules as observed in the inset from Figure 
6A). The stabilization of carbohydrate matrices by polyphenols has been described and attributed 
to the presence of physical interactions between both components (Floriano-Sánchez et al., 2006). 
It is worth noting that, even though chitosan is soluble in acidic media, extract-loaded 
microcapsules could not be completely dissolved in acidic buffer (results not shown), 
corroborating the previous hypothesis.  
   In the case of the tablets (Figure 6B), swelling was much more gradual considering the different 
specific surface areas of both delivery vehicles (being much higher in the case of the 
microcapsules) and the fact that the material was compacted in a press, producing a denser 
material with slower water diffusion properties.  
3.6. In-vitro release of plant extracts from microcapsules and tablets in a buffer system and 
in simulated vaginal fluid (SVF) 
   The release of plant extracts from electrosprayed chitosan microcapsules in aqueous buffer 
(PBS, pH = 4.5) was studied and compared with the release of the same plant extracts from 
conventional vaginal tablets. The amount of released extract was significantly higher from 
chitosan electrosprayed microcapsules than from tablets for all assayed plant extracts. In chitosan 
microcapsules, a very fast release of phenolic compounds in the first 4-5 hours was observed, 
which is the typical behavior of the release from hydrophilic matrices, due to the fast matrix 
swelling upon contact with an aqueous release medium (Atay et al., 2017). The level of released 
phenolic compounds from conventional vaginal tablets until 5 h was much lower than for 
microcapsules. The dispersion of the extracts was considerably better in electrosprayed 
microcapsules than in tablets, explained by the different preparation method, which affected their 
exposure to the release medium, especially due to the larger surface area of microparticles. Both 
the solvent used for preparing encapsulation solutions and the interweaving of polysaccharide 













medium upon hydration of chitosan microcapsules, leading to a very fast release in the first 4-5 
hours. In contrast, extract accumulations could be visually observed in conventional vaginal 
tablets, suggesting a poor miscibility of the extracts with the tablet ingredients. These extract 
clusters remained insoluble even after the disintegration of the tablets (they could still be visually 
observed in the release suspension). In brief, the encapsulation of extracts within chitosan 
electrosprayed particles increased their solubility (and thus their release) in aqueous medium 
compared to their formulation in traditional vaginal tablets in the first hours. However, after 24 h, 
100% of the extract incorporated was released from the tablets except for T. andina (80%). 
It is interesting to note that the release from the chitosan microcapsules was higher than expected, 
probably due to the previous solubility of the extracts in the acid media which apparently made 
some of the phenolic compounds more accessible in the release media. In fact, it has been 
previously reported that the properties of chitosan promote a closer contact between the 
phytopharmaceutical form and the vaginal tissue, thus increasing the residence time of bioactive 
compounds at the site of administration (Albertini et al., 2009; Martin-Villena et al., 2013; 
Caramella et al., 2015).   
To predict the content of phenolic compounds released from microcapsules and tablets using in-
vitro conditions which mimicked the in-vivo scenario, both vaginal formulations were also 
included in SVF for 24 h. Under our experimental conditions, the released total phenolic 
percentages were in all cases in the range of 90 to 100% for microcapsules and tablets (Figure 7 A 
and B). Our results have shown a good release of bioactive compounds in SVF for all assayed 
plant extracts. HPLC-DAD was used to analyze the individual phenolic compounds from 
polyphenols released from the microcapsules and tablets, to ascertain whether encapsulation or the 
inclusion in tablets affected their stability. The chromatography profile of each of them was 














































3.7. Biological activities from plant extracts released from microcapsules and tablets  
 
3.7.1. Antifungal activity 
   Adequate treatment of fungal infections such as candidiasis is difficult as the fungi are 
eukaryotic organisms with a structure and metabolism like that of eukaryotic host. Furthermore, 
long-term treatments with commonly used antifungal drugs, such as polyenes and azoles, have 
toxic effects and result in strain resistance. For this reason, it is necessary to find new natural 
products with antifungal activity. The antifungal activity of dry extracts of five medicinal plants 
used in Argentina as antifungal agents, either alone or incorporated within microcapsules and 
tablets, was assayed in vitro against 10 yeast strains obtained from vaginal exudates of patients 
with yeast infection. They included three strains of Saccharomyces cerevisiae, three strains of C. 
albicans, three strains of C. glabrata and one strain of C. tropicalis. Some S. cerevisiae and C. 
albicans and non-albicans strains were azole-susceptible (85%) or resistant (15%). The Candida 
and Saccharomyces species were also susceptible to nystatin and amphotericin B.  Dry extracts 
and the extracts eluted from microcapsules and tablets were effective against C. albicans and non-
albicans in macrodilutions assays. The MIC values on C. albicans of phenolic compounds eluted 
from microcapsules and tablets containing Z. punctata, L. divaricata and L. nitida extracts were 
lower than MIC values of the ones containing L. cuneifolia, and T. andina (Table 3). The MIC 
values of phenolic compounds eluted from microcapsules and tablets were like the MIC values of 
the corresponding dry extract used to obtain vaginal formulations. The highest activity of Z. 
punctata microcapsules and tablets on Candida species could be attributed to the content of 2′,4′-
dihydroxychalcone and 2′,4′-dihydroxy-3′-methoxychalcone, two compounds with demonstrated 
antifungal activities (Isla et al., 2016; Nuño et al., 2014). These compounds were also effective 
inhibitors in biofilm formation as well as on pre-formed Candida biofilm and yeast germ tube 
formation. Furthermore, chalcones can inhibit exoenzymes, which are responsible for the invasion 
mechanisms of Candida. All these effects could moderate colonization, thereby suppressing the 
pathogen invasive potential (Nuño et al., 2014). All the formulations obtained from L. divaricata 
were more active on S. cerevisiae than the ones from T. andina. The products with T. andina 
contained a higher level of hydrolysed tannins of type of pedunculangins and casuarins (Moreno et 
al., 2018a). The hydrolysed tannins are compounds with demonstrated anti Candida activity. 
There are some evidences that the mentioned compounds affect fungal cells through interaction 
with the lipid bilayer of the cell membrane. They could act by disrupting the membrane integrity 
or by intercalation into cell wall (Martins et al., 2015; Sieniawska & Baj, 2017). Furthermore, the 













Our results are consistent with powerful fungicidal activity in all cases, both in the extracts and in 
the phyto-formulations. Tangarife-Castaño et al. (2011) suggested a classification system for 
antifungal activity in plant derivatives based on MIC values as strong inhibitors (MIC of < 0.5 
mg/mL); moderate inhibitors (MIC of 0.6-1.5 mg/mL); and weak inhibitors (MIC of > 1.6 
mg/mL). Therefore, Zp, Ln, Lc, Ld and Ta extracts as well as their phytoformulations could be 




































                                   MIC values represent growth inhibition as compared with control growth. E: extract; M: microcapsules; T: tablets.  













MIC (µg GAE/mL) 
Yeast  Collection 
number 
E M T E M T E M T E M T E M T 
C. albicans 144783 400 400 400 100 100 100 100 100 100 50 50 50 400 400 400 
C. albicans 134333 400 400 400 100 100 100 100 100 100 100 100 100 400 400 400 
C. albicans 2089 400 400 400 100 100 100 100 100 100 50 50 50 400 400 400 
C. glabrata 031646 400 400 400 100 100 100 50 50 50 25 25 25 400 400 400 
C. glabrata 042030 400 400 400 50 50 50 50 50 50 50 50 50 400 400 400 
C. glabrata 031982 400 400 400 50 50 50 50 50 50 25 25 25 400 400 400 
C. tropicalis 1841 400 400 400 100 100 100 100 100 100 100 100 100 400 400 400 
Saccharomyces 
cerevisiae 
134528 50 50 50 50 50 50 50 50 50 25 25 25 25 25 25 
S. cerevisiae 134544 100 100 100 50 50 50 50 50 50 50 50 50 >400 >400 >400 
S. cerevisiae 124263 50 50 50 25 25 25 50 50 50 25 25 25 400 400 400 
ATCC C. 
parapsilosis. 
134410 400 400 400 100 100 100 100 100 100 100 100 100 400 400 400 
ATCC C. 
krusei 












3.7.2. Antioxidant capacity   
Candida-vaginal epithelial cell interactions in vaginal infections promote the liberation 
of free radicals and a local inflammatory response that results in mucosal damage 
(Fisher, 2012). For this reason, a treatment with drugs with multiple effects, anti-
Candida, antioxidant and anti-inflammatory can be more effective. The antioxidant 
activity of L. cuneifolia, L. divaricata, L. nitida, and T. andina extracts in ethanol 60° in 
free cell systems was previously reported (Moreno et al., 2018a, b). In this work, the 
antioxidant activity of extracts was confirmed and the antioxidant activity of Z. punctata 
extract, other Argentina medicinal plant, was assayed in a free cell system and a cell 
system. The antioxidant capacity of polyphenolic compounds enriched extracts was 
compared with the activity of released phenolics from microcapsules and tablets 
containing the medicinal plant extracts. The T. andina extract was more active as 
ABTS•+ scavenger than L. divaricata, followed by Z. punctata, L. cuneifolia, and L. 
nitida with SC50 values of 1.68±0.2; 2.68±0.10; 3.2±0.2; 4.10±0.2 and 4.50±0.3 µg 
GAE/mL, respectively (Table 4). The antioxidant activity of T. andina ethanolic extract 
could be attributed to the content of caffeoyl quinic acid, HHDP, bis HDDP hexosides 
(pedunculangins) and galloyl HHDP hexosides (casuarins) (Sieniawska & Baj, 2017).   
In the assay of the oxidative hemolysis inhibition, Z. punctata exhibited a stronger 
inhibitory effect on lipoperoxidation of red blood cells followed by L. cuneifolia, L. 
nitida, L. divaricata and T. andina, with IC50 values of 0.05±0.004; 0.12±0.01; 
0.21±0.01; 0.22±0.02; 0.23±0.01 µg GAE/mL. The phytoformulations were able not 
only to reduce ABTS but also to prevent and limit the release of lysosomal enzymes 
from human red blood cell to the extracellular matrix indicating that they could be able 
to prevent damage on neutrophils membrane reducing the inflammatory response with 
similar potency to the medicinal extracts. The antioxidant capacity in all cases was 
higher than those of commercial natural and synthetic antioxidant compounds used in 
pharmaceutical products (Table 4). It has been reported that phenolic compounds were 
able to bind covalently to membrane proteins and by hydrogen bonding with the polar 
head groups of phospholipids, resulting in the protection of erythrocyte (Bonarska-
Kujawa et al. (2012, 2015). This interaction provides a certain level of protection for 














Table 4. Antioxidant activities of dry extract, microcapsules and tablets containing dry extracts 
and commercial reference drugs. 
E: extract; M: microcapsules; T: tablets. BHT: butylated hydroxytoluene; NDGA: Nordihydroguaiaretic acid. Values 
are reported as mean ± standard deviation of triplicates. Different letters in the same column for each plant species 
indicated significant differences in the antioxidant activity according to Tukey's test (p ≤ 0.05). 
 
 
Conclusions    
   This work demonstrates that the dry extracts of L. cuneifolia, L. divaricata, L. nitida, 
Z. punctata and T. andina could be used to treat vulvovaginal candidiasis as they have 
shown strong antifungal and antioxidant capacity. The development of chitosan 
   CD50 ABTS•⁺ (µg/ml) CI50 AAPH (µg/ml) 
Larrea 
cuneifolia 
E 4.10±0.20f,g,h 0.12±0,01a,b 
M 4.20±0.20f,g,h 0.13±0.01a,b,c 
T 4.66±0.20h,i 0.14±0.01a,b,c,d 
Larrea 
divaricata 
E 2.68±0.10c 0.22±0.02b,c,d,e 
M 3.10±0.20c,d,e 0.24±0.02d,e 
T 2.90±0.10c,d 0.23±0.01c,d,e 
Larrea 
nitida 
E 4.50±0.30g,h,i 0.21±0.01b,c,d,e 
M 6.00±0.30j 0.26±0.02e 
T 5.00±0.30i 0.23±0.01c,d,e 
Zuccagnia 
punctata 
E 3.20±0.2c,d,e 0.05±0.004a 
M 3.80±0.3e,f,g 0.09±0.003a 
T 3.70±0.4e,f 0.08±0.003a 
Tetraglochin 
andina 
E 1.68±0.2a 0.23±0.01c,d,e 
M 1.80±0.2a 0.29±0.02e 
T 1.90±0.3a,b 0.28±0.01e 
Reference 
compounds 
BHT 3.50 ±0.20d,e,f 1.20 ± 0.10g 
Quercetin 1.40 ± 0.10a 0.90 ± 0.08f 













microcapsules and tablets as vaginal formulations containing the plant extracts, did not 
affect the biological properties of the extracts. A different release rate of bioactive 
compounds from microcapsules and tablets was observed in the first hours, being faster 
in chitosan microcapsules. This fact could be attributed to the higher specific surface of 
the electrosprayed microcapsules. Moreover, the solubility of the selected extracts was 
favored by microcapsule formation, thus potentially increasing the bioavailability of the 
active compounds in the vaginal environment. The encapsulation of the whole dry 
extracts could be a practical and more economical way than isolated bioactive 
compounds encapsulation.  
 
Conflict of interest 
The authors declare they have no conflict of interest. 
 
Acknowledgements 
This research was supported by grants from Secretaría de Ciencia, Arte e Innovación 
Tecnológica de la Universidad Nacional de Tucumán, Argentina (SCAIT-UNT), 
Consejo Nacional de Investigaciones Científicas y Técnicas, Argentina (CONICET), 
Agencia Nacional de Promoción Científica y Tecnológica (ANPCyT), Universidad de 
Talca, Chile (PIEI-QUIM-BIO) and EMHE-CSIC (Grant MHE-200038). L. G. Gómez-
Mascaraque, is recipient of a predoctoral contract (BES-2013-065883) from the Spanish 
Ministry of Economy, Industry and Competitiveness (MINECO). The authors thank the 
Central Support Service for Experimental Research (SCSIE) of the University of 
Valencia for the electronic microscopy service. 
 
References 
Agüero, M. B., Svetaz, L., Sánchez, M., Luna, L., Lima, B., López, M. L., Zacchino, S., 
Palermo, J., Wunderlin, D., Feresin, G. E., & Tapia, A. (2011). Argentinean 
Andean propolis associated with the medicinal plant Larrea nitida Cav. 
(Zygophyllaceae). HPLC-MS and GC-MS characterization and antifungal activity. 
Food and Chemical Toxicology, 49, 1970-1978. 
https://doi.org/10.1016/j.fct.2011.05.008. 
Albertini, B., Passerini, N., Di Sabatino, M., Vitali, B., Brigidi, P., & Rodriguez, L. 













congealing for the vaginal delivery of econazole nitrate. European Journal of 
Pharmaceutical Sciences, 36, 591–601. https://doi.org/10.1016/j.ejps.2008.12.009. 
Andersen, T., Mishchenko, E., Flaten, G. E., Sollid, J. U. E., Mattsson, S., Tho, I., & 
Škalko-Basnet, N. (2017). Chitosan-Based Nanomedicine to Fight 
Genital Candida Infections: Chitosomes. Marine Drugs, 15, 64. 
http://doi.org/10.3390/md15030064. 
Atay, E., Fabra, M.J., Martínez-Sanz, M., Gomez-Mascaraque, L.G., Altan, A, & 
Lopez-Rubio, A. (2018). Development and characterization of chitosan/gelatin 
electrosprayed microparticles as food grade delivery vehicles for anthocyanin 
extracts. Food Hydrocolloids, 77, 699-710. http://doi.org/ 10.1016/j.foodhyd.2017. 
11.011 
Azevedo, E. P., Santhana Mariappan, S. V., & Kumar, V. (2012). Preparation and 
characterization of chitosans carrying aldehyde functions generated by nitrogen 
oxides. Carbohydrate Polymers, 87(3), 1925-1932. 
https://doi.org/10.1016/j.carbpol.2011.09.090. 
Bandara, H. M. H. N., Matsubara, V. H. & Samaranayake, L. P. (2017). Future 
therapies targeted towards eliminating Candida biofilms and associated infections, 
Expert Review of Anti-infective Therapy, 15(3), 299-318, 
https://doi.org/10.1080/14787210.2017.1268530. 
Barboza, G., Cantero, J., Nuñez, C., Pacciaroni, A., & Ariza Espinar, L. (2009). 
Medicinal plants: A general review and a phytochemical and 
ethnopharmacological screening of the native Argentine Flora. Kurtziana, 34(1-2), 
7-365.  
Bigucci, F., Abruzzo, A., Vitali, B., Saladini, B., Cerchiara, T., Gallucci, M. C., & 
Luppi, B. (2015). Vaginal inserts based on chitosan and carboxymethylcellulose 
complexes for local delivery of chlorhexidine: Preparation, characterization and 
antimicrobial activity. International Journal of Pharmaceutics, 478(2), 456-463. 
https://doi.org/10.1016/j.ijpharm.2014.12.008. 
Blecha, J. E., Anderson, M. O., Chow, J. M., Guevarra, C. C., Pender, C., Penaranda, 
C., Zavodovskaya, M., Youngren, J. F., Berkman, C. E. (2007). Inhibition of IGF-
1R and lipoxygenase by nordihydroguaiaretic acid (NDGA) analogs. Bioorganic 
and Medicinal Chemistry Letters, 17(14), 4026,4029. 
https://doi.org/10.1016/j.bmcl.2007.04.092. 













anthocyanins with erythrocytes and liposome membranes. Cell Molecular Biology 
Letter, 17, 289-308. https://doi.org/10.2478/s11658-012-0010-y. 
Bonarska-Kujawa, D., Cyboran-Mikołajczyk, S., & Kleszczyńska, H. (2015). Molecular 
mechanism of action of chlorogenic acid on erythrocyte and lipid membrane. 
Molecular Membrane Biological, 32, 46,54. 
https://doi.org/10.3109/09687688.2015.1031833. 
Bradshaw, C. S., & Sobel, J. D. (2016). Current Treatment of Bacterial Vaginosis-
Limitations and Need for Innovation. The Journal of Infectious Diseases, 214(1),  
S14-S20. https://doi.org/10.1093/infdis/jiw159. 
Butassi, E., Svetaz, L. A., Ivancovich, J. J., Feresin, G. E., Tapia, A., & Zacchino, S. A. 
(2015). Synergistic mutual potentiation of antifungal activity of Zuccagnia 
punctata Cav. and Larrea nitida Cav. extracts in clinical isolates of Candida 
albicans and Candida glabrata. Phytomedicine, 22, 666-678. 
https://doi.org/10.1016/j.phymed.2015.04.004. 
Carabajal, M. P. A., Isla, M. I., & Zampini, I. C. (2016). Evaluation of antioxidant and 
antimutagenic activity of herbal teas from native plants used in traditional 
medicine in Argentina. South African Journal of Botany, 110, 258-265. 
https://doi.org/10.1016/j.sajb.2016.10.006. 
Chakraborty, S., Liao, I. C., Adler, A., & Leong, K. W. (2009). Electrohydrodynamics: 
A facile technique to fabricate drug delivery systems. Advanced Drug Delivery 
Reviews, 61(12), 1043-1054. https://doi.org/10.1016/j.addr.2009.07.013. 
CLSI. (2012). Reference method for broth dilution antifungal susceptibility testing of 
yeasts; 4th informational supplement. Clinical and Laboratory Standards Institute, 
Villanova PA. 
Costamagna, M. S., Ordoñez, R. M., Zampini, I. C., Sayago, J. E., & Isla, M. I. (2013). 
Nutritional and antioxidant properties of Geoffroea decorticans, an Argentinean 
fruit, and derived products (flour, arrope, decoction and hydroalcoholic beverage). 
Food Research International, 54(1), 160-168. 
https://doi.org/10.1016/j.foodres.2013.05.038. 
das Neves, J., Pinto, E., Teixeira, B., Dias, G., Rocha, P., Cunha, T., Santos, B., Amaral, 
M. H., & Bahia, M. F. (2008). Vulvovaginal candidosis. Drugs, 68, 1787-1802. 
https://doi.org/10.2165/00003495-200868130-00002. 
Ensign, L. M., Cone, R., & Hanes, J. (2014) Nanoparticle-based drug delivery to the 














Fisher, G., (2012). Chronic vulvovaginal candidiasis: What we know and what we have 
yet to learn. Australasian Journal of Dermatology, 53, 247-254. 
https://doi.org/10.1111/j.1440-0960.2011.00860.x. 
Floriano-Sánchez, E., Villanueva, C., Medina-Campos, O. N., Rocha, D., Sánchez-
González, D. J., Cárdenas-Rodríguez, N., & Pedraza-Chaverrí, J. (2006). 
Nordihydroguaiaretic acid is a potent in vitro scavenger of peroxynitrite, singlet 
oxygen, hydroxyl radical, superoxide anion and hypochlorous acid and prevents in 
vivo ozone-induced tyrosine nitration in lungs. Free Radical Research, 40(5), 523-
533. https://doi.org/10.1080/10715760500419365. 
Gómez-Mascaraque, L. G., Lagarón, J. M., & López-Rubio, A. (2015). Electrosprayed 
gelatin submicroparticles as edible carriers for the encapsulation of polyphenols of 
interest in functional foods. Food Hydrocolloids, 49, 42-52. 
https://doi.org/10.1016/j.foodhyd.2015.03.006. 
Gómez-Mascaraque, & López-Rubio, A. (2016). Protein-based emulsion electrosprayed 
micro- and submicroparticles for the encapsulation and stabilization of 
thermosensitive bioactives. Journal of Colloid and Interface Science, 465, 259-
270. https://doi.org/10.1016/jcis.2015.11.061. 
Gómez-Mascaraque, L.G., Ambrosio-Martín, J., Fabra, M.J., Pérez-Masiá, R.,  López-
Rubio, A. (2016). “Novel nanoencapsulation structures for functional foods and 
nutraceutical applications”. In: “Nanotechnology in Nutraceuticals: Production to 
Consumption” edited by Shampa Sen and Yashwant Pathak and published by 
Taylor & Francis Group LLC (Boca Raton, FL, USA). Chapter 20, 375-398. ISBN 
9781498721882. 
Gómez-Mascaraque, G., Dhital, S., López-Rubio, A., Gidley, M. (2017). Dietary 
polyphenols bind to potato cells and cellular components. Journal of Functional 
Foods, 37, 283-292. https://doi.org/10.1016/j.jff.2017.07.062. 
Gómez-Mascaraque, L. G., Sanchez, G., & López-Rubio, A. (2016). Impact of 
molecular weight on the formation of electrosprayed chitosan microcapsules as 
delivery vehicles for bioactive compounds. Carbohydrate Polymers, 150, 121-130. 
https://doi.org/10.1016/j.carbpol.2016.05.012. 
Gómez-Mascaraque, L. G., Méndez, J. A., Fernández-Gutiérrez, M., Vázquez, B., & 
San Román, J. (2014). Oxidized dextrins as alternative crosslinking agents for 













10(2), 798-811. https://doi.org/10.1016/j.actbio.2013.10.003. 
Isla, M. I., Moreno, M. A., Nuño, G., Rodriguez, F., Carabajal, A., Rosa, A. M., & 
Catiana, Z. I. (2016). Zuccagnia punctata: A review of its traditional uses, 
phytochemistry, pharmacology and toxicology. Natural Product Communications, 
11, 1-7. 
Isla, M. I., Salas, A., Danert, F. C., Zampini, I. C., & Ordoñez, R. M. (2014). Analytical 
methodology optimization to estimate the content of non-flavonoid phenolic 
compounds in Argentine propolis extracts. Pharmaceutical Biology, 52(7), 835-
840. https://doi.org/10.3109/13880209.2013.871638. 
Knapczyk, J.,  Macura, A. B., & Pawlik, B. (1992). Simple tests demonstrating the 
antimycotic effect of chitosan. International Journal of Pharmaceutics, 80, 33-38. 
https://doi.org/10.1016/0378-5173(92)90259-5. 
Le Bourvellec, C. & Renard, C. M. G. C. (2012). Interactions between Polyphenols and 
Macromolecules: Quantification Methods and Mechanisms. Critical Reviews in 
Food Science and Nutrition, 52(3), 213-248. 
https://doi.org/10.1080/10408398.2010.499808. 
Le Bourvellec, C., Guyot, S. & Renard, C.M. (2004). Non-covalent interaction between 
procyanidins and apple cell wall material: Part I. Effect of some environmental 
parameters. Biochimica et Biophysica Acta, 1672(3), 192-202. 
https://doi.org/10.1016/j.bbagen.2004.04.001. 
Li, X. , Jin, L. J., Lu, Y. N., Zhen, Y. H., Li, S. Y., Wang, L. H., & Xu, Y. P. (2009). 
Chitosan-alginate microcapsules for oral delivery of egg yolk immunoglobulin 
(IgY): effects of chitosan concentration. Applied Biochemistry and Biotechnology, 
159(3), 778-787. doi: 10.1007/s12010-009-8628-6.  
Li, Y., Maciel, D., Rodrigues, J, Shi, X., & Tomás, H. (2015). Biodegradable Polymer 
Nanogels for Drug/Nucleic Acid Delivery. Chemical Review, 115, 8564−8608. 
http://dx.doi.org/10.1021/cr500131f. 
Li, Y., Xiao, Y. & Liu, C. (2017). The Horizon of Materiobiology: A Perspective on 
Material-Guided Cell Behaviors and Tissue Engineering. Chemical Review, 117 (5), 
4376–4421. http://dx.doi.org/10.1021/acs.chemrev.6b00654. 
Marciello, M., Silvia, R., Caramella, C., & Remuñan-López, C. (2017). Freeze-dried 













Carbohydrate Polymers, 170, 43- 51.  http://dx.doi.org/10.1016/j.carbpol.2017. 
04.051. 
Martino, R., Arcos, M. L. B., Alonso, R., Sülsen, V., Cremaschi, G., & Anesini, C. 
(2016). Polyphenol-rich fraction from Larrea divaricata and its main flavonoid 
quercetin-3-methyl ether induce apoptosis in lymphoma cells through nitrosative 
stress. Phytotherapy Research, 30(7), 1128-1136. https://doi.org/10.1002/ptr.5615. 
Martins, N., Barros, L., Henriques, M., Silva, S., & Ferreira, I. (2015) Activity of 
phenolic compounds from plant origin against Candida species. Industrial Crops 
and Products, 74, 648–670. http://doi.org/10.1016/j.indcrop.2015.05.067. 
Martin-Villena, M.J., Fernandez-Campos, F., Calpena-Campmany, A.C., Bozal-de 
Febrer, N., Ruiz-Martinez, M.A., & Clares-Naveros, B. (2013) Novel 
microparticulate systems for the vaginal delivery of nystatin: development and 
characterization, Carbohydrate Polymers 94, 1-11. 
Mendes, L., De Freitas, V., Baptista, P., & Carvalho, M. (2011). Comparative 
antihemolytic and radical scavenging activities of strawberry tree (Arbutus unedo 
L.) leaf and fruit. Food and Chemical Toxicology, 49(9), 2285-2291. 
https://doi.org/10.1016/j.fct.2011.06.028. 
Moreno, M. A., Córdoba, S., Zampini, I. C., Mercado, M. I., Ponessa, G., Alberto, M. 
R., Nader-Macias, M. E. F., Sayago, J., Burgos-Edwards, A., Schmeda-
Hirschmann, G., & Isla, M. I. (2018). Tetraglochin andina Ciald.: A medicinal 
plant from the Argentinean highlands with potential use in vaginal candidiasis. 
Journal of Ethnopharmacology, 216, 283-294. https://doi.org/10.1016/j.jep.2018. 
01.001. 
Moreno, M. A., Córdoba, S., Zampini, I. C., Mercado, M. I., Ponessa, G., Sayago, J. E., 
Pino Ramos, L. L., Schmeda-Hirschmann, G., & Isla, M. I. (2018). Argentinean 
Larrea dry extracts with potential use in vaginal candidiasis. Natural Product 
Communications, 13(2), 171-174. https://doi.org/10.1080/13531040802284544. 
Nuño, G., Alberto, M., Zampini, I., Cuello, S., Ordoñez, R., Sayago, J., Baroni, V., 
Wunderlin, D., & Isla, M. I. (2014). The effect of Zuccagnia punctata Cav, an 
Argentina medicinal plant, on virulence factors from Candida species. Natural 
Product Communications, 9, 933-936. 
Quiroga, E., Sampietro, A., & Vattuone, M. (2001). Screening antifungal activities of 














Sawant, B., & Khan, T. (2017). Recent advances in delivery of antifungal agents for 
therapeutic management of candidiasis. Biomedicine & Pharmacotherapy, 96, 
1478-1490. https://doi.org/10.1016/j.biopha.2017.11.127. 
Sieniawska, E. & Baj, T., (2017). Tannins. Plant Metabolites: Their Chemistry. Medical 
University of Lublin, Lublin, Poland. Chapter 10. 
http://dx.doi.org/10.1016/B978 -0-12-802104-0.00010-X. 
Sivam, A. S., Sun-Waterhouse, D., Perera, C. O., & Waterhouse, G. I. N. (2012). 
Exploring the interactions between blackcurrant polyphenols, pectin and wheat 
biopolymers in model breads; A FTIR and HPLC investigation. Food Chemistry, 
131(3), 802–810. https://doi.org/10.1016/j.foodchem.2011.09.047. 
Stege, P. W., Davicino, R. C., Vega, A. E., Casali, Y. A., Correa, S., & Micalizzi, B. 
(2006). Antimicrobial activity of aqueous extracts of Larrea divaricata Cav 
(jarilla) against Helicobacter pylori. Phytomedicine, 13(9-10), 724-727. 
https://doi.org/10.1016/j.phymed.2005.06.008. 
Svetaz, L., Zuljan, F., Derita, M., Petenatti, E., Tamayo, G., Cáceres, A., Cechinel 
Filho, V., Giménez, A., Pinzón, R., Zacchino, S. A., & Gupta, M. (2010). Value of 
the ethnomedical information for the discovery of plants with antifungal properties. 
A survey among seven Latin American countries. Journal of Ethnopharmacology, 
127, 137-158. https://doi.org/10.1016/j.jep.2009.09.034. 
Tangarife-Castaño, V., Correa-Royero, J., Zapata-Londoño, B., Durán, C., Stanshenko, 
E., & Mesa-Arango, A.C. (2011). Anti-Candida albicans activity, cytotoxicity 
and interaction with antifungal drugs of essential oils and extracts from aromatic 
and medicinal plants. Infection, 11, 160-167. https://doi.org/10.1016/S0123-
9392(11)70080-7. 
Torres, R., Urbina, F., Morales, C., Modak, B., & Delle Monache, F. (2003). 
Antioxidant properties of lignans and ferulic acid from the resinous exudate of 
Larrea nitida. Journal of the Chilean Chemical Society, 48, 61-63. 
https://doi.org/10.4067/S0717-97072003000300012. 
Torres Carro, R., Isla, M. I., Ríos, J. L., Giner, R. M., & Alberto, M. R. (2015). Anti-
inflammatory properties of hydroalcoholic extracts of Argentine Puna plants. Food 
Research International, 67, 230-237. https://doi.org/10.1016/j.foodres.2014. 
11.012. 













vitro and in vivo of extracts and lignans isolated from Larrea divaricata Cav. 
against phytopathogenic fungus. Industrial Crops and Products, 42, 583-586. 
https://doi.org/10.1016/j.indcrop.2012.06.009. 
Wong, T. W., Dhanawat, M., & Rathbone, M. J. (2014). Vaginal drug delivery: 
strategies and concerns in polymeric nanoparticle development. Expert Opinion on 
Drug Delivery, 11(9), 1419-34. https://doi.org/10.1517/17425247.2014.924499.  
Zampini, I., Cudmani, N., & Isla, M. (2007). Actividad antimicrobiana de plantas 
medicinales argentinas sobre bacterias antibiótico-resistentes. Acta Bioquímica 
Clínica Latinoamericana, 41, 385-393. 
 
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
